When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Kahn is a particular fan of the peptides NAD+ and glutathione—which, she says, “work synergistically to help with energy, ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

GLP-1 drugs like Wegovy and Ozempic are designed to treat type 2 diabetes, but are widely known for their effect on weight ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects of semaglutides.

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...